CGRP – new perspectives in headache management

Three new takes on the potential for calcitonin gene-related proteins were presented at this year’s virtual EHF conference that could influence the management of not only migraine but also persistent post-traumatic headache and medication overuse headache.


Our correspondent’s highlights from the symposium are meant as a fair representation of the scientific content presented. The views and opinions expressed on this page do not necessarily reflect those of Lundbeck.

  1. Schwedt et al. 2020. In review.
  2. Tepper et al. Headache 2019; 59 (S1):162-163
  3. Zheng et al. J Neuroscience 2010;30:8807-8814
  4. Schain et al. J Neuroscience 2017;7:2904-2915
  5. Schain et al. Ann Neurol 2018;83:508-21
  6. Schain et al. J Neuroscience 2019;39:6001-6011
  7. Burstein et al. J Neurosci 2015; 35:6619-6629
  8. Tepper & Spears. Neurol Clin 2009;27;417-427
Country selection
We are registering that you are located in Brazil - if that's correct then please continue to Progress in Mind Brazil
You are leaving Progress in Mind
Please confirm your email
We have just sent you an email, with a confirmation link.
Before you can gain full access - you need to confirm your email.
The information on this site is exclusively intented for health care professionals.
All the information included in the Website is related to products of the local market and, therefore, directed to health professionals legally authorized to prescribe or dispense medications with professional practice. The technical information of the drugs is provided merely informative, being the responsibility of the professionals authorized to prescribe drugs and decide, in each concrete case, the most appropriate treatment to the needs of the patient.
Register for access to Progress in Mind in your country